Cancer Institute A national cancer institute
designated cancer center

Quynh-Thu Le, MD

Publication Details

  • Nonsurgical therapy for stages I and II non-small cell lung cancer HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA Le, Q. T., Petrik, D. W. 2005; 19 (2): 237-?

    Abstract:

    For patients who have stages I and II non-small cell lung cancer (NSCLC) and who are unable or unwilling to undergo surgical resection, nonsurgical treatment modalities have been used with curative intent. Conventionally fractionated radiotherapy has been the mainstay of nonsurgical therapy; however, advances in technology and the clinical application of radiobiologic principles have allowed more accurately targeted treatment that delivers higher effective doses to the tumor, while respecting the tolerance of surrounding normal tissues. This article discusses nonsurgical approaches to the treatment of early-stage NSCLC, including several promising techniques, such as radiation dose escalation, altered radiation fractionation, stereotactic radiotherapy, and radiofrequency ablation.

    View details for DOI 10.1016/j.hoc.2005.02.003

    View details for Web of Science ID 000228810400004

    View details for PubMedID 15833405

Stanford Medicine Resources:

Footer Links: